Claims In Securities Class Action Against Drug Maker Found To Be Insufficient

Mealey's (April 3, 2018, 2:04 PM EDT) -- NEW YORK — Although lead plaintiffs in a securities class action against a drug company and its co-founders have shown that the defendants acted with the requisite scienter, they have failed...
To view the full article, register now.